Sr. Director, Corporate Controller @ (December 2019 - November 2021)
Sr. Director, Corporate Controller @ Concert Pharmaceuticals, Inc. (March 2017 - November 2019)
Associate Director, Financial Reporting @ Concert Pharmaceuticals, Inc. (January 2016 - March 2017)
Senior Manager, Financial Reporting @ Concert Pharmaceuticals, Inc. (May 2014 - December 2015)
Accounting Manager (Consultant) @ (November 2013 - May 2014)
Accounting Manager @ (December 2012 - August 2013)
Manager of Accounting @ (August 2012 - December 2012)
SEC Reporting Accountant @ (March 2009 - August 2012)
Experienced Associate @ (August 2006 - March 2009)
Ryan Lynch Education
University of Massachusetts Amherst
Master of Science (MS) (Accounting)
2006-2007
Isenberg School of Management, UMass Amherst
Bachelor of Business Administration (BBA) (Accounting)
2002-2006
Ryan Lynch Skills
10Q
Account Reconciliation
Accounting
Accounts Payable
Accounts Receivable
Auditing
Budgets
CPA
Cash Flow
Cost Accounting
Finance
Financial Accounting
Financial Analysis
Financial Reporting
Forecasting
GAAP
General Ledger
Great Plains Software
Internal Controls
Mergers
Mergers & Acquisitions
Microsoft Excel
Microsoft Office
Microsoft Word
PowerPoint
Process Improvement
QuickBooks
Revenue Recognition
SEC filings
Sarbanes-Oxley Act
Strategic Planning
US GAAP
Public Speaking
Sarbanes Oxley Act
Project Management
Mergers and Acquisitions
Ryan Lynch Summary
Ryan Lynch, based in Boston, MA, US, is currently a SVP Finance and Chief Accounting Officer at Crescent Biopharma. Ryan Lynch brings experience from previous roles at Kelonia Therapeutics, Morphic Therapeutic and Concert Pharmaceuticals, Inc.. Ryan Lynch holds a 2006 - 2007 Master of Science (MS) in Accounting @ University of Massachusetts Amherst. With a robust skill set that includes 10Q, Account Reconciliation, Accounting, Accounts Payable, Accounts Receivable and more. Ryan Lynch has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Ryan Lynch?
Find contact details for 700 million professionals.